Linda Rogers, MD is currently the Clinical Director of the Adult Asthma Program at the Mount Sinai National Jewish Health Respiratory Institute at the Icahn School of Medicine in New York. Her current clinical and research interests focus on difficult-to control and severe refractory asthma, advanced therapies for severe refractory asthma, and on the intersection between digital technology and asthma research and clinical care. She has been an investigator in the American Lung Association Airways Clinical Research Centers since 2001 performing clinical trials of treatments for asthma and COPD that directly impact clinical practice. She is the medical director of the Clinical Trials Office for the Department of Medicine at the Icahn School of Medicine at Mount Sinai and oversees execution of over 100 clinical trials in 8 subspecialties. She is the Principal Investigator of the REGAIN study, Real World and Genomics Data Based Insight Through Network Analysis Study, a longitudinal observational study looking to characterize patients across the spectrum of asthma severity via systems biology and digital technologies.